FDA approves Botox to treat chronic migraine
The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.
Oct 15, 2010
Latest in Home
Automotive Execs Predict a New Competitive Order by 2035
October 22, 2026
NEXT S13 Toolbox a Heavy-Duty, Multi-Zone Workshop on Wheels
October 22, 2026


















